Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TransCon IL-2 beta/gamma |
Synonyms | |
Therapy Description |
TransCon IL-2 beta/gamma is a hydrogel based formulation of an IL-2 variant, which may lead to activation of cytotoxic T-lymphocytes and NK cells, and increased antitumor immune response, potentially resulting in tumor cell death (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TransCon IL-2 beta/gamma | TransCon IL-2b/g | TransCon IL-2 beta/gamma is a hydrogel based formulation of an IL-2 variant, which may lead to activation of cytotoxic T-lymphocytes and NK cells, and increased antitumor immune response, potentially resulting in tumor cell death (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05081609 | Phase Ib/II | TransCon IL-2 beta/gamma Pembrolizumab + TransCon IL-2 beta/gamma | IL Believe: A Study of TransCon IL-2 beta/gamma Alone or in Combination With Pembrolizumab or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (IL Believe) | Recruiting | USA | POL | ITA | ESP | CAN | BEL | AUS | 3 |